Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 13; p. 944740
Main Authors Wei, Cheng, Wang, Bo, Peng, Dazhao, Zhang, Xiaoyang, Li, Zesheng, Luo, Lin, He, Yingjie, Liang, Hao, Du, Xuezhi, Li, Shenghui, Zhang, Shu, Zhang, Zhenyu, Han, Lei, Zhang, Jianning
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 23.06.2022
Subjects
ALKBH5
glioma
immune
Immunology
lncRNA-miRNA-ALKBH5 network
pan-cancer
prognosis
Online AccessGet full text

Cover

More Information
Bibliography:corrigendum
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
These authors have contributed equally to this work
Edited and reviewed by: Quan Cheng, Central South University, China
This article was submitted to Cancer Immunity and Immunotherapy, a section of the journal Frontiers in Immunology
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2022.944740